Evidence map›Paper›PMID 41234054›Full record

ArticleBioinformatics (Oxford, England)2025

Integrative Metabolic-Flux Platform for Analysis, Contextualization, and Targeting (IMPACT): bridging untargeted and targeted flux analysis.

Collin Starke, Janneke Hendriks, Judith Wahrheit, Frank Fluitman, Jules Beekwilder, Florence Miramella Schempp, Karsten Hiller

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Collin StarkeDepartment of Bioinformatics and Biochemistry, Technische Universität Braunschweig, Niedersachsen, Braunschweig 38106, Germany.ORCID 0000-0002-2938-9940
Janneke HendriksBASF Metabolome Solutions GmbH, Berlin 10589, Germany.
Judith WahrheitComputational Biology, BASF SE, Ludwigshafen am Rhein 67056, Germany.
Frank FluitmanIsobionics BV, Geleen 6167RD, The Netherlands.
Jules BeekwilderIsobionics BV, Geleen 6167RD, The Netherlands.
Florence Miramella SchemppIndustrial Biotechnology, BASF SE, Ludwigshafen am Rhein 67056, Germany.
Karsten HillerDepartment of Bioinformatics and Biochemistry, Technische Universität Braunschweig, Niedersachsen, Braunschweig 38106, Germany.ORCID 0000-0001-9322-5820

Funding

Deutsche Forschungsgemeinschaft 432325352Deutsche Forschungsgemeinschaft 536691227
6 · The paper itself

Abstract

summaryThe "Integrative Metabolic-Flux Platform for Analysis, Contextualization, and Targeting" (IMPACT) is a comprehensive, fully modular platform designed for both targeted and untargeted metabolomics analysis in stable-isotope labeling experiments. It facilitates the accurate calculation of mass isotopomer distributions (MIDs) and the annotation of unknown metabolites with a contextualization algorithm, addressing the challenges in metabolomics research. IMPACT integrates an entire preprocessing pipeline for LC-MS data, including peak picking, feature grouping, and peak filling, along with advanced features for isotope detection, MID calculation, and its core feature contextualization, enabling metabolite integration into biological pathway networks. The platform supports various file formats and offers user-friendly online access, making it accessible for researchers seeking to elucidate metabolic pathways and networks with precision and reliability. AVAILABILITY AND IMPLEMENTATION: IMPACT is implemented in Python 3.9 and R 4.3.2, with a front-end in Javascript utilizing the Cytoscape.js library for data visualization. It is available as a docker container and can be accessed online at https://impact.bioinfo.nat.tu-bs.de, providing a user-friendly interface for metabolomics data analysis.

Indexed as

Metabolic Flux AnalysisMetabolomicsSoftwareAlgorithmsChromatography, LiquidIsotope LabelingMetabolic Networks and Pathways

Identifiers

PMID41234054
PMCPMC12684724

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.